Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

BL2082

Bladder disease spectrum (bladder cancer progression) tissue array, 202 cases/208 cores
Unstained: $455.00 Add to Cart
Trial (BL2082t*): $150.00 Add to Cart
H&E (BL2082s*): $455.00 Add to Cart

Microarray Panel:Bladder (urocystic) cancer tissue microarray, containing 129 cases of transitional cell carcinoma, 5 squamous cell carcinoma, 2 adenocarcinoma, 1 undifferentiated carcinoma, 3 each of carcinoma sarcomatodes, metastatic carcinoma and papilloma, 2 pheochromocytoma, 12 hyperplasia, 40 inflammation, 2 adjacent normal tissue and 6 normal tissue, single core per case
Cores:208
Cases:202
Layout:16 cols × 13 rows
Core Diameter:1 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade TNM Type †
A1 1 F 28 Bladder Papillary transitional cell carcinoma 1 T1N0M0 Malignant
A2 2 M 35 Bladder Papillary transitional cell carcinoma 1 T1N0M0 Malignant
A3 3 M 56 Bladder Papillary transitional cell carcinoma 1 T1N0M0 Malignant
A4 4 M 66 Bladder Papillary transitional cell carcinoma 1 T1N0M0 Malignant
A5 5 M 76 Bladder Papillary transitional cell carcinoma (sparse) 1 T1N0M0 Malignant
A6 6 M 42 Bladder Papillary transitional cell carcinoma 1 T1N0M0 Malignant
A7 7 F 58 Bladder Papillary transitional cell carcinoma 1 T1N0M0 Malignant
A8 8 M 54 Bladder Papillary transitional cell carcinoma (fibrous tissue and blood vessel) – T2aN0M0 Malignant
A9 9 M 46 Bladder Papillary transitional cell carcinoma 1 T1N0M0 Malignant
A10 10 M 72 Bladder Papillary transitional cell carcinoma 1 T1N0M0 Malignant
A11 11 M 80 Bladder Papillary transitional cell carcinoma 1 T1N0M0 Malignant
A12 12 M 53 Bladder Papillary transitional cell carcinoma 1 T1N0M0 Malignant
A13 13 M 69 Bladder Papillary transitional cell carcinoma (sparse) 1 T1N0M0 Malignant
A14 14 M 50 Bladder Papillary transitional cell carcinoma 1 T1N0M0 Malignant
A15 15 F 31 Bladder Papillary transitional cell carcinoma (fibrous tissue and blood vessel) – T1N0M0 Malignant
A16 16 M 72 Bladder Papillary transitional cell carcinoma 1 T1N0M0 Malignant
B1 17 F 72 Bladder Papillary transitional cell carcinoma 1 T1N0M0 Malignant
B2 18 M 71 Bladder Papillary transitional cell carcinoma 1 T1N0M0 Malignant
B3 19 M 39 Bladder Papillary transitional cell carcinoma 1 T2N0M0 Malignant
B4 20 M 68 Bladder Papillary transitional cell carcinoma 1 T2N0M0 Malignant
B5 21 M 60 Bladder Papillary transitional cell carcinoma 1 T2N0M0 Malignant
B6 22 F 50 Bladder Papillary transitional cell carcinoma 1 T1N0M0 Malignant
B7 23 M 76 Bladder Papillary transitional cell carcinoma 1 T1N0M0 Malignant
B8 24 M 50 Bladder Papillary transitional cell carcinoma 1 T1N0M0 Malignant
B9 25 M 51 Bladder Papillary transitional cell carcinoma (sparse) 2 T1N0M0 Malignant
B10 26 M 68 Bladder Papillary transitional cell carcinoma 1 T2N0M0 Malignant
B11 27 M 80 Bladder Transitional cell carcinoma 1 T2N0M0 Malignant
B12 28 M 51 Bladder Papillary transitional cell carcinoma 1 T2N0M0 Malignant
B13 29 F 70 Bladder Papillary transitional cell carcinoma 1 T1N0M0 Malignant
B14 30 M 66 Bladder Papillary transitional cell carcinoma 1 T3N0M0 Malignant
B15 31 M 85 Bladder Papillary transitional cell carcinoma 1 T1N0M0 Malignant
B16 32 M 40 Bladder Papillary transitional cell carcinoma 1 T1N0M0 Malignant
C1 33 F 61 Bladder Papillary transitional cell carcinoma 1 T1N0M0 Malignant
C2 34 M 61 Bladder Papillary transitional cell carcinoma 1–2 T1N0M0 Malignant
C3 35 M 68 Bladder Papillary transitional cell carcinoma 1–2 T1N0M0 Malignant
C4 36 M 66 Bladder Papillary transitional cell carcinoma 1–2 T1N0M0 Malignant
C5 37 M 74 Bladder Papillary transitional cell carcinoma 2 T1N0M0 Malignant
C6 38 F 74 Bladder Papillary transitional cell carcinoma 2 T1N0M0 Malignant
C7 39 M 60 Bladder Papillary transitional cell carcinoma 1 T2N0M0 Malignant
C8 40 M 53 Bladder Papillary transitional cell carcinoma 2 T3biN0M0 Malignant
C9 41 M 79 Bladder Papillary transitional cell carcinoma 2 T1N0M0 Malignant
C10 42 M 40 Bladder Papillary transitional cell carcinoma 2 T1N0M0 Malignant
C11 43 M 69 Bladder Papillary transitional cell carcinoma (sparse) 2 T1N0M0 Malignant
C12 44 M 67 Bladder Papillary transitional cell carcinoma 2 T1N0M0 Malignant
C13 45 M 78 Bladder Papillary transitional cell carcinoma 2 T1N0M0 Malignant
C14 46 M 70 Bladder Papillary transitional cell carcinoma 2 T1N0M0 Malignant
C15 47 M 59 Bladder Transitional cell carcinoma 2 T3biN0M0 Malignant
C16 48 M 67 Bladder Papillary transitional cell carcinoma 2 T1N0M0 Malignant
D1 49 M 76 Bladder Transitional cell carcinoma 2 T1N0M0 Malignant
D2 50 M 53 Bladder Transitional cell carcinoma 2 T2N0M0 Malignant
D3 51 M 79 Bladder Papillary transitional cell carcinoma 2 T2N0M0 Malignant
D4 52 M 51 Bladder Papillary transitional cell carcinoma 1–2 T1N0M0 Malignant
D5 53 M 71 Bladder Papillary transitional cell carcinoma 1–2 T2N0M0 Malignant
D6 54 M 69 Bladder Papillary transitional cell carcinoma 1–2 TaN0M0 Malignant
D7 55 M 60 Bladder Papillary transitional cell carcinoma with necrosis 1 T1N0M0 Malignant
D8 56 M 67 Bladder Papillary transitional cell carcinoma 1–2 T1N0M0 Malignant
D9 57 M 70 Bladder Papillary transitional cell carcinoma 1–2 T1N0M0 Malignant
D10 58 M 79 Bladder Papillary transitional cell carcinoma 1–2 T1N0M0 Malignant
D11 59 M 65 Bladder Papillary transitional cell carcinoma 1–2 T1N0M0 Malignant
D12 60 M 52 Bladder Papillary transitional cell carcinoma 1–2 T1N0M0 Malignant
D13 61 M 71 Bladder Papillary transitional cell carcinoma 1–2 T1N0M0 Malignant
D14 62 M 60 Bladder Papillary transitional cell carcinoma 1–2 T1N0M0 Malignant
D15 63 M 56 Bladder Papillary transitional cell carcinoma 1–2 T1N0M0 Malignant
D16 64 M 68 Bladder Papillary transitional cell carcinoma 2 T1N0M0 Malignant
E1 65 M 60 Bladder Papillary transitional cell carcinoma 1 T2N0M0 Malignant
E2 66 F 37 Bladder Papillary transitional cell carcinoma 2 T1N0M0 Malignant
E3 67 M 53 Bladder Papillary transitional cell carcinoma 2 T1N0M0 Malignant
E4 68 M 56 Bladder Papillary transitional cell carcinoma 2 T1N0M0 Malignant
E5 69 M 58 Bladder Papillary transitional cell carcinoma 2 T2aN0M0 Malignant
E6 70 M 50 Bladder Papillary transitional cell carcinoma 2 T2N0M0 Malignant
E7 71 M 57 Bladder Transitional cell carcinoma 3 T2N0M0 Malignant
E8 72 M 69 Bladder Papillary transitional cell carcinoma 2 T1N0M0 Malignant
E9 73 F 59 Bladder Papillary transitional cell carcinoma 2 T1N0M0 Malignant
E10 74 M 61 Bladder Papillary transitional cell carcinoma 2 T2N0M0 Malignant
E11 75 M 65 Bladder Transitional cell carcinoma 2–3 T2N0M0 Malignant
E12 76 M 70 Bladder Papillary transitional cell carcinoma (smooth muscle) – T2N0M0 Malignant
E13 77 F 80 Bladder Papillary transitional cell carcinoma 2 T2N0M0 Malignant
E14 78 M 25 Bladder Transitional cell carcinoma 2 T2N0M0 Malignant
E15 79 M 70 Bladder Papillary transitional cell carcinoma 2 T2aN0M0 Malignant
E16 80 M 62 Bladder Papillary transitional cell carcinoma 2 T2N0M0 Malignant
F1 81 M 70 Bladder Papillary transitional cell carcinoma 2 T1N0M0 Malignant
F2 82 F 50 Bladder Papillary transitional cell carcinoma 2 T1N0M0 Malignant
F3 83 M 55 Bladder Papillary transitional cell carcinoma 2 T1N0M0 Malignant
F4 84 M 51 Bladder Papillary transitional cell carcinoma 2 T3N0M0 Malignant
F5 85 M 43 Bladder Transitional cell carcinoma (sparse) 2 T1N0M0 Malignant
F6 86 M 50 Bladder Papillary transitional cell carcinoma 2 T2aN0M0 Malignant
F7 87 F 60 Bladder Transitional cell carcinoma 2 T2bN0M0 Malignant
F8 88 M 74 Bladder Transitional cell carcinoma 2 T1N0M0 Malignant
F9 89 F 46 Bladder Transitional cell carcinoma 2 T1N0M0 Malignant
F10 90 M 57 Bladder Transitional cell carcinoma 2 T2N0M0 Malignant
F11 91 M 79 Bladder Transitional cell carcinoma (fibrous tissue and blood vessel) – T1N0M0 Malignant
F12 92 M 70 Bladder Transitional cell carcinoma 2 T2N0M0 Malignant
F13 93 F 52 Bladder Transitional cell carcinoma 2 T2N0M0 Malignant
F14 94 F 49 Bladder Transitional cell carcinoma 2 T2N0M0 Malignant
F15 95 M 47 Bladder Transitional cell carcinoma 2 T2N0M0 Malignant
F16 96 M 72 Bladder Transitional cell carcinoma 2 T2N0M0 Malignant
G1 97 M 58 Bladder Transitional cell carcinoma 2–3 T3N0M0 Malignant
G2 98 M 74 Bladder Transitional cell carcinoma 3 T3N0M0 Malignant
G3 99 F 49 Bladder Transitional cell carcinoma 3 T3N0M0 Malignant
G4 100 M 49 Bladder Transitional cell carcinoma 3 T2N0M0 Malignant
G5 101 F 60 Bladder Transitional cell carcinoma 3 T2N0M0 Malignant
G6 102 F 31 Bladder Transitional cell carcinoma 3 T2N0M0 Malignant
G7 103 M 66 Bladder Transitional cell carcinoma 3 T3N0M0 Malignant
G8 104 F 49 Bladder Transitional cell carcinoma 3 T2N0M0 Malignant
G9 105 M 78 Bladder Transitional cell carcinoma 3 T2N0M0 Malignant
G10 106 M 72 Bladder Transitional cell carcinoma 3 T2N0M0 Malignant
G11 107 M 66 Bladder Transitional cell carcinoma 3 T1N0M0 Malignant
G12 108 M 65 Bladder Transitional cell carcinoma 3 T3N0M0 Malignant
G13 109 F 44 Bladder Transitional cell carcinoma 3 T4N0M0 Malignant
G14 110 M 72 Bladder Transitional cell carcinoma 3 T3N0M0 Malignant
G15 111 M 42 Bladder Transitional cell carcinoma 3 T3N0M0 Malignant
G16 112 M 85 Bladder Papillary transitional cell carcinoma 3 T3N0M0 Malignant
H1 113 M 39 Bladder Transitional cell carcinoma 3 T1N0M0 Malignant
H2 114 F 50 Bladder Transitional cell carcinoma 3 T1N0M0 Malignant
H3 115 M 72 Bladder Transitional cell carcinoma 3 T3aiN0M0 Malignant
H4 116 M 74 Bladder Transitional cell carcinoma 3 T4N0M0 Malignant
H5 117 M 60 Bladder Transitional cell carcinoma 3 T1N0M0 Malignant
H6 118 M 58 Bladder Transitional cell carcinoma 3 T2N0M0 Malignant
H7 119 M 74 Bladder Transitional cell carcinoma 3 T2N0M0 Malignant
H8 120 F 30 Bladder Papillary transitional cell carcinoma 2 T1N0M0 Malignant
H9 121 M 76 Bladder Transitional cell carcinoma 3 T3N0M0 Malignant
H10 122 M 71 Bladder Transitional cell carcinoma 3 T3N0M0 Malignant
H11 123 M 70 Bladder Transitional cell carcinoma 3 T3N0M0 Malignant
H12 124 M 70 Bladder Transitional cell carcinoma 3 T3N0M0 Malignant
H13 125 F 44 Bladder Transitional cell carcinoma 3 T3N0M0 Malignant
H14 126 M 54 Bladder Transitional cell carcinoma 3 T2N0M0 Malignant
H15 127 M 63 Bladder Transitional cell carcinoma 3 T1N0M0 Malignant
H16 128 M 52 Bladder Transitional cell carcinoma 3 T3N0M0 Malignant
I1 129 F 57 Bladder Transitional cell carcinoma 3 T2aN0M0 Malignant
I2 130 M 65 Bladder Squamous cell carcinoma 3 T2aN0M0 Malignant
I3 131 M 68 Bladder Squamous cell carcinoma 1 T3aN0M0 Malignant
I4 132 M 74 Bladder Squamous cell carcinoma 1 T2aN0M0 Malignant
I5 133 M 57 Bladder Squamous cell carcinoma 1 T3N0M0 Malignant
I6 134 M 67 Bladder Squamous cell carcinoma 2 T3aN0M0 Malignant
I7 135 M 55 Bladder Adenocarcinoma 2 T2N0M0 Malignant
I8 136 M 69 Bladder Adenocarcinoma 3 T3bN0M0 Malignant
I9 137 M 68 Bladder Undifferentiated carcinoma 4 T3bN0M0 Malignant
I10 138 M 54 Bladder Carcinoma sarcomatodes – T3aN0M0 Malignant
I11 139 M 50 Bladder Carcinoma sarcomatodes – T3bN0M0 Malignant
I12 140 F 74 Bladder Carcinoma sarcomatodes – T3aN0M0 Malignant
I13 141 M 51 Lymph node Metastatic squamous cell carcinoma 2–3 – Metastasis
I14 142 M 55 Soft tissue Metastatic transitional cell carcinoma 3 – Metastasis
I15 143 M 61 Cerebrum Metastatic transitional cell carcinoma 3 – Metastasis
I16 144 M 48 Bladder Inverted papilloma – – Benign
J1 145 F 40 Bladder Inverted papilloma – – Benign
J2 146 M 64 Bladder Inverted papilloma – – Benign
J3 147 M 17 Bladder Pheochromocytoma – – Benign
J4 148 M 67 Bladder Pheochromocytoma – – Benign
J5 149 M 63 Bladder Mild hypereplasia of urothelium of No. 174 – – Hyperplasia
J6 150 M 44 Bladder Mild atypical hypereplasia of urothelium – – Hyperplasia
J7 151 M 67 Bladder Mild hypereplasia of urothelium – – Hyperplasia
J8 152 M 70 Bladder Mild hypereplasia of urothelium – – Hyperplasia
J9 153 M 45 Bladder Moderate-severe hypereplasia of urothelium – – Hyperplasia
J10 154 F 40 Bladder Mild hypereplasia of urothelium (chronic inflammation of urocystic mucosa) – – Hyperplasia
J11 155 F 72 Bladder Mild hypereplasia of urothelium (fibrous tissue and blood vessel) – – Hyperplasia
J12 156 M 68 Bladder Mild hypereplasia of urothelium – – Hyperplasia
J13 157 M 79 Bladder Hypereplasia of urothelium (fibrous tissue and blood vessel) of No. 91 – – Hyperplasia
J14 158 M 33 Bladder Moderate hypereplasia of urothelium – – Hyperplasia
J15 159 F 57 Bladder Hypereplasia of urothelium (fibrous tissue and blood vessel) – – Hyperplasia
J16 160 M 47 Bladder Hypereplasia of urothelium (fibrous tissue and blood vessel) – – Hyperplasia
K1 161 M 40 Bladder Chronic inflammation of urocystic mucosa – – Inflammation
K2 162 F 48 Bladder Chronic inflammation of urocystic mucosa (fibrous tissue and blood vessel) – – Inflammation
K3 163 M 42 Bladder Chronic inflammation of urocystic mucosa – – Inflammation
K4 164 F 71 Bladder Chronic inflammation of urocystic mucosa (sparse) – – Inflammation
K5 165 M 73 Bladder Chronic inflammation of urocystic mucosa – – Inflammation
K6 166 M 63 Bladder Chronic inflammation of urocystic mucosa (prostate tissue) – – Inflammation
K7 167 M 55 Bladder Chronic inflammation of urocystic mucosa – – Inflammation
K8 168 M 61 Bladder Chronic inflammation of urocystic mucosa – – Inflammation
K9 169 M 36 Bladder Cystitis glandularis – – Inflammation
K10 170 M 47 Bladder Chronic inflammation of urocystic mucosa (with hyperplasia) – – Inflammation
K11 171 F 75 Bladder Chronic inflammation of urocystic mucosa (fibrous tissue and blood vessel) – – Inflammation
K12 172 M 43 Bladder Chronic inflammation of urocystic mucosa – – Inflammation
K13 173 M 50 Bladder Chronic inflammation of urocystic mucosa (sparse) – – Inflammation
K14 174 M 63 Bladder Cystitis glandularis – – Inflammation
K15 175 M 70 Bladder Chronic inflammation of urocystic mucosa – – Inflammation
K16 176 F 74 Bladder Chronic inflammation of urocystic mucosa (fibrous tissue and blood vessel) of No. 38 – – Inflammation
L1 177 F 72 Bladder Chronic inflammation of urocystic mucosa – – Inflammation
L2 178 F 58 Bladder Chronic inflammation of urocystic mucosa (smooth muscle and blood vessel) – – Inflammation
L3 179 M 53 Bladder Chronic inflammation of urocystic mucosa – – Inflammation
L4 180 M 59 Bladder Chronic inflammation of urocystic mucosa of No. 47 – – Inflammation
L5 181 M 42 Bladder Chronic inflammation of urocystic mucosa – – Inflammation
L6 182 F 48 Bladder Chronic inflammation of urocystic mucosa (smooth muscle and blood vessel) – – Inflammation
L7 183 M 54 Bladder Chronic inflammation of urocystic mucosa (smooth muscle and blood vessel) – – Inflammation
L8 184 M 60 Bladder Chronic inflammation of urocystic mucosa (smooth muscle and blood vessel) – – Inflammation
L9 185 M 78 Bladder Chronic inflammation of urocystic mucosa (fibrous tisue and blood vessel) – – Inflammation
L10 186 F 47 Bladder Chronic inflammation of urocystic mucosa – – Inflammation
L11 187 M 68 Bladder Chronic inflammation of urocystic mucosa (sparse) – – Inflammation
L12 188 M 62 Bladder Chronic inflammation of urocystic mucosa (fibrous tissue and blood vessel) – – Inflammation
L13 189 M 65 Bladder Chronic inflammation of urocystic mucosa – – Inflammation
L14 190 M 72 Bladder Chronic inflammation of urocystic mucosa (fibrous tissue and blood vessel) – – Inflammation
L15 191 M 58 Bladder Cystitis glandularis – – Inflammation
L16 192 M 73 Bladder Chronic inflammation of urocystic mucosa – – Inflammation
M1 193 M 69 Bladder Chronic inflammation of urocystic mucosa – – Inflammation
M2 194 M 62 Bladder Chronic inflammation of urocystic mucosa (sparse) – – Inflammation
M3 195 M 60 Bladder Chronic inflammation of urocystic mucosa – – Inflammation
M4 196 M 67 Bladder Chronic inflammation of urocystic mucosa – – Inflammation
M5 197 M 58 Bladder Chronic inflammation of urocystic mucosa (fibrous tissue and blood vessel) – – Inflammation
M6 198 M 65 Bladder Chronic inflammation of urocystic mucosa (fibrous tissue and blood vessel) of No. 108 – – Inflammation
M7 199 M 50 Bladder Chronic inflammation of urocystic mucosa – – Inflammation
M8 200 F 70 Bladder Chronic inflammation of urocystic mucosa – – Inflammation
M9 201 M 62 Bladder Cancer adjacent normal urocystic tissue – – NAT
M10 202 M 56 Bladder Cancer adjacent normal urocystic tissue of No. 63 – – NAT
M11 203 M 43 Bladder Normal urocystic tissue – – Normal
M12 204 M 50 Bladder Normal urocystic tissue (sparse) – – Normal
M13 205 M 35 Bladder Normal urocystic tissue – – Normal
M14 206 M 5 Mon. Bladder Normal urocystic tissue – – Normal
M15 207 M 48 Bladder Normal urocystic tissue – – Normal
M16 208 F 15 Bladder Normal urocystic tissue (sparse) – – Normal
– – M 58 Skin Malignant melanoma (tissue marker) – Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal